News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Kumar Neil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 50,697 shares
@ $14.09, valued at
$714.3k
Sold 51,552 shares
@ $14.0095, valued at
$722.2k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0
Exercised 33,544 restricted stock units
@ $0 |
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/03/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $10.9602, valued at
$1.3M
|
|
| 02/21/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 23,908 shares
@ $12.64, valued at
$302.2k
Sold 44,798 shares
@ $12.7031, valued at
$569.1k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,395 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 624,652 options to buy
@ $11.41, valued at
$7.1M
Granted 536,704 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $11.0058, valued at
$1.3M
|
|
| 01/06/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $7.6738, valued at
$920.9k
|
|
| 12/21/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 200,000 shares
@ $0 |
|
| 11/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 34,066 shares
@ $9.64, valued at
$328.4k
Sold 34,640 shares
@ $9.3997, valued at
$325.6k
Exercised 5,130 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 27,697 shares
@ $11.08, valued at
$306.9k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 05/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 23,759 shares
@ $6.74, valued at
$160.1k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 03/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 489,456 restricted stock units
@ $0 |
|
| 02/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,085 shares
@ $8.84, valued at
$27.3k
Exercised 5,130 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0 |
|
| 02/14/2022 |
SC 13G/A
| Kumar Neil reports a 6% stake in BridgeBio Pharma, Inc. |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,730 shares
@ $47.25, valued at
$176.2k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0 |
|
| 10/29/2021 |
3
| Kumar Neil (Director) has filed a Form 3 on LianBio |
| 08/18/2021 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,730 shares
@ $49.48, valued at
$184.6k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0 |
|
| 05/18/2021 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,731 shares
@ $53.66, valued at
$200.2k
Exercised 5,130 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0 |
|
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,774 shares
@ $44.33, valued at
$78.6k
Exercised 5,129 restricted stock units
@ $0 |
|
| 08/18/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,774 shares
@ $28.53, valued at
$50.6k
Exercised 5,129 restricted stock units
@ $0 |
|
| 08/05/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 63,017 shares
@ $27.2277, valued at
$1.7M
Sold 3,040 shares
@ $28.1244, valued at
$85.5k
Sold 7,184 shares
@ $26.7046, valued at
$191.8k
Sold 6,759 shares
@ $27.3582, valued at
$184.9k
|
|
| 07/06/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 50,625 shares
@ $30.6266, valued at
$1.6M
Sold 33,700 shares
@ $31.6719, valued at
$1.1M
Sold 2,700 shares
@ $32.415, valued at
$87.5k
Sold 56,445 shares
@ $30.2245, valued at
$1.7M
|
|
| 06/10/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 10,600 shares
@ $30.0118, valued at
$318.1k
|
|
| 06/05/2020 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 5,930 shares
@ $30.0461, valued at
$178.2k
Granted 590,551 options to buy
@ $28.86, valued at
$17M
Granted 82,069 restricted stock units
@ $0 |
|
|
|
|